No takes yet. Share an insight, caveat, or question.
Genomic analysis reveals that TP53 mutations increase genomic instability across 10,225 patients in 32 cancer types, highlighting extensive downstream pathway alterations.
Donehower et al. (2019) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: